Omega-3 Polyunsaturated Fatty Acids and Stroke Burden

Stroke is a major leading cause of death and disability worldwide. N-3 polyunsaturated fatty acids (PUFAs) including eicosapentaenoic acid and docosahexaenoic acid have potent anti-inflammatory effects, reduce platelet aggregation, and regress atherosclerotic plaques. Since the discovery that the Gr...

Full description

Bibliographic Details
Published in:International Journal of Molecular Sciences
Main Authors: Yuji Ueno, Nobukazu Miyamoto, Kazuo Yamashiro, Ryota Tanaka, Nobutaka Hattori
Format: Text
Language:English
Published: Multidisciplinary Digital Publishing Institute 2019
Subjects:
Online Access:https://doi.org/10.3390/ijms20225549
_version_ 1821504861004365824
author Yuji Ueno
Nobukazu Miyamoto
Kazuo Yamashiro
Ryota Tanaka
Nobutaka Hattori
author_facet Yuji Ueno
Nobukazu Miyamoto
Kazuo Yamashiro
Ryota Tanaka
Nobutaka Hattori
author_sort Yuji Ueno
collection MDPI Open Access Publishing
container_issue 22
container_start_page 5549
container_title International Journal of Molecular Sciences
container_volume 20
description Stroke is a major leading cause of death and disability worldwide. N-3 polyunsaturated fatty acids (PUFAs) including eicosapentaenoic acid and docosahexaenoic acid have potent anti-inflammatory effects, reduce platelet aggregation, and regress atherosclerotic plaques. Since the discovery that the Greenland Eskimo population, whose diet is high in marine n-3 PUFAs, have a lower incidence of coronary heart disease than Western populations, numerous epidemiological studies to explore the associations of dietary intakes of fish and n-3 PUFAs with cardiovascular diseases, and large-scale clinical trials to identify the benefits of treatment with n-3 PUFAs have been conducted. In most of these studies the incidence and mortality of stroke were also evaluated mainly as secondary endpoints. Thus, a systematic literature review regarding the association of dietary intake of n-3 PUFAs with stroke in the epidemiological studies and the treatment effects of n-3 PUFAs in the clinical trials was conducted. Moreover, recent experimental studies were also reviewed to explore the molecular mechanisms of the neuroprotective effects of n-3 PUFAs after stroke.
format Text
genre eskimo*
Greenland
genre_facet eskimo*
Greenland
geographic Greenland
geographic_facet Greenland
id ftmdpi:oai:mdpi.com:/1422-0067/20/22/5549/
institution Open Polar
language English
op_collection_id ftmdpi
op_coverage agris
op_doi https://doi.org/10.3390/ijms20225549
op_relation Bioactives and Nutraceuticals
https://dx.doi.org/10.3390/ijms20225549
op_rights https://creativecommons.org/licenses/by/4.0/
op_source International Journal of Molecular Sciences; Volume 20; Issue 22; Pages: 5549
publishDate 2019
publisher Multidisciplinary Digital Publishing Institute
record_format openpolar
spelling ftmdpi:oai:mdpi.com:/1422-0067/20/22/5549/ 2025-01-16T21:44:53+00:00 Omega-3 Polyunsaturated Fatty Acids and Stroke Burden Yuji Ueno Nobukazu Miyamoto Kazuo Yamashiro Ryota Tanaka Nobutaka Hattori agris 2019-11-07 application/pdf https://doi.org/10.3390/ijms20225549 EN eng Multidisciplinary Digital Publishing Institute Bioactives and Nutraceuticals https://dx.doi.org/10.3390/ijms20225549 https://creativecommons.org/licenses/by/4.0/ International Journal of Molecular Sciences; Volume 20; Issue 22; Pages: 5549 stroke omega-3 PUFA eicosapentaenoic acid docosahexaenoic acid Text 2019 ftmdpi https://doi.org/10.3390/ijms20225549 2023-07-31T22:46:14Z Stroke is a major leading cause of death and disability worldwide. N-3 polyunsaturated fatty acids (PUFAs) including eicosapentaenoic acid and docosahexaenoic acid have potent anti-inflammatory effects, reduce platelet aggregation, and regress atherosclerotic plaques. Since the discovery that the Greenland Eskimo population, whose diet is high in marine n-3 PUFAs, have a lower incidence of coronary heart disease than Western populations, numerous epidemiological studies to explore the associations of dietary intakes of fish and n-3 PUFAs with cardiovascular diseases, and large-scale clinical trials to identify the benefits of treatment with n-3 PUFAs have been conducted. In most of these studies the incidence and mortality of stroke were also evaluated mainly as secondary endpoints. Thus, a systematic literature review regarding the association of dietary intake of n-3 PUFAs with stroke in the epidemiological studies and the treatment effects of n-3 PUFAs in the clinical trials was conducted. Moreover, recent experimental studies were also reviewed to explore the molecular mechanisms of the neuroprotective effects of n-3 PUFAs after stroke. Text eskimo* Greenland MDPI Open Access Publishing Greenland International Journal of Molecular Sciences 20 22 5549
spellingShingle stroke
omega-3 PUFA
eicosapentaenoic acid
docosahexaenoic acid
Yuji Ueno
Nobukazu Miyamoto
Kazuo Yamashiro
Ryota Tanaka
Nobutaka Hattori
Omega-3 Polyunsaturated Fatty Acids and Stroke Burden
title Omega-3 Polyunsaturated Fatty Acids and Stroke Burden
title_full Omega-3 Polyunsaturated Fatty Acids and Stroke Burden
title_fullStr Omega-3 Polyunsaturated Fatty Acids and Stroke Burden
title_full_unstemmed Omega-3 Polyunsaturated Fatty Acids and Stroke Burden
title_short Omega-3 Polyunsaturated Fatty Acids and Stroke Burden
title_sort omega-3 polyunsaturated fatty acids and stroke burden
topic stroke
omega-3 PUFA
eicosapentaenoic acid
docosahexaenoic acid
topic_facet stroke
omega-3 PUFA
eicosapentaenoic acid
docosahexaenoic acid
url https://doi.org/10.3390/ijms20225549